Shanghai Yuhan Chemical Co, Ltd. - chemistry life science chemical reagent analysis chromatography Materials Science

FDC-chemical

Shanghai Yuhan Pharmaceutical focuses on the field of small molecule chemical new drugs, providing services throughout the discovery, synthesis, and optimization of drug molecular blocks. Its business covers small-scale, pilot, and commercial production. Intended to provide high-quality products and services for global new drug companies, CRO/CMO laboratories, and university research institutes, helping them make significant scientific discoveries faster and promote human progress.

Discovery

Molecular blocks are important fragments that make up drug molecules, and Yuhan Pharmaceutical has constructed a diverse and novel structure

Process development and optimization

Process development and optimization

Yuhan Pharmaceutical adheres to continuous technological innovation and has been committed to process development and optimization services for many years.

Production

We provide customers with development and production services of API starting materials and advanced intermediates

HIgt Purity

We are specialized in the production of semiconductor, FPD flat panel display, crystalline silicon solar energy, led, lithium battery, etc

R&D and innovation

R&D and innovation

We focus on R&D and innovation. Yuhan is a scientist in Chinese universities, scientific research institutes, laboratories and pharmaceutical enterprises

Product Center

Yuhan's business involves the R&D, production and sales of drug molecular blocks and high-end chemical reagents for R&D

Quality control

Quality control

We pay special attention to quality control, and use iso9001:2015 quality management system standard throughout the whole operation of the company.

MSDS and COA

CoA | MSDS download, strict product quality inspection, and a complete set of quality inspection spectra can be downloaded

Focus on the field of small molecule chemical new drugs

Provide high-quality products and services for global drug R&D institutions

NEWS

These bizarre ancient species are rewriting animal evolution

These bizarre ancient species are rewriting animal evolution

Early fossils with guts, segmented bodies and other sophisticated features reveal a revolution in animal life — before the Cambrian explosion.

Fresh evidence challenges the consensus view of active sites in an industrial catalyst

Fresh evidence challenges the consensus view of active sites in an industrial catalyst

A study of the industrial catalyst titanium silicalite-1 suggests that the conventional view of the structure of its active sites is wrong. The findings might enable further optimization of related industrial catalysts.

Integrity, professionalism, innovation,win-win

Building a closed-loop system of business R&D production delivery with customers and employees based on trust

Rapid sample delivery ability and reliable problem-solving ability

Focusing on talent and building R&D centers with different characteristic technology platforms

Stable production and delivery capacity and complete quality system

Efficient connection between R&D center and factory to ensure supply stability and cost competitiveness

Reliable project PM management system and trusted IP protection system, communicating with customers

PRODUCT

1-METHYL-5-AMINOINDOLE

Cart

tert-Butyl ((1R,2R)-2-(hydroxymethyl)cyclopropyl)carbamate

Cart

5-PHENYL-1H-PYRAZOLE-3-CARBOXYLIC ACID

Cart

Cart（0）

尚未添加任何产品